NCT01837290 - Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Chronic Renal FailureHip Fracture

Interventions

DRUG

dexmedetomidine infusion for premedication

Group Dexmedetomidine (Group D): Midazolam 0.02 mg/kg + 0.5 μg/kg/10 min dexmedetomidine infusion for premedication; Spinal block (Hyperbaric bupivacaine 0.5% 12.5 mg) (n=30)

DRUG

Midazolam

intravenous Midazolam 0.02 mg/kg for premedication

DRUG

saline infusion

Saline infusion to facilitate blinding

DRUG

Spinal block with hyperbaric bupivacaine 0.5% 12.5 mg

Hyperbaric bupivacaine injection for spinal block

Trial Locations (3)

01250

Baskent University School of Medicine Adana Research and Teaching Center, Adana

Baskent University School of Medicine Adana Teaching and Research Center, Adana

Baskent University School of Medicine Adana Teaching and Research Hospital, Adana

All Listed Sponsors

lead

Baskent University

OTHER